Uncoupling nuclear receptor LXR and cholesterol metabolism in cancer

Cell Metabolism

Volumn 21, Issue 4, 2015, Pages 517-526

  Bovenga, Fabiola ^a,b   Sabbà, Carlo ^a   Moschetta, Antonio ^a,b  

^a UNIVERSITY OF BARI   (Italy)

^b NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LIVER X RECEPTOR; OXYSTEROL; TRANSCRIPTION FACTOR; TRANSCRIPTOME; CHOLESTEROL; ORPHAN NUCLEAR RECEPTOR;

APOPTOSIS; CATABOLISM; CELL CYCLE REGULATION; CELL PROLIFERATION; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; HUMAN; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; DRUG EFFECTS; GENE EXPRESSION REGULATION; LIVER; METABOLISM; MOUSE; NEOPLASMS; PHYSIOLOGY; REGENERATION;

ANIMALS; CHOLESTEROL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER; MICE; MODELS, BIOLOGICAL; NEOPLASMS; ORPHAN NUCLEAR RECEPTORS; REGENERATION; TRANSCRIPTOME;

EID: 84928408498     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2015.03.002     Document Type: Review

References (92)

1. R. Apfel, D. Benbrook, E. Lernhardt, M.A. Ortiz, G. Salbert, and M. Pfahl A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily Mol. Cell. Biol. 14 1994 7025 7035
2. A. Baron, T. Migita, D. Tang, and M. Loda Fatty acid synthase: a metabolic oncogene in prostate cancer? J. Cell. Biochem. 91 2004 47 53
3. S.J. Bensinger, M.N. Bradley, S.B. Joseph, N. Zelcer, E.M. Janssen, M.A. Hausner, R. Shih, J.S. Parks, P.A. Edwards, B.D. Jamieson, and P. Tontonoz LXR signaling couples sterol metabolism to proliferation in the acquired immune response Cell 134 2008 97 111
4. I. Björkhem, D. Lütjohann, U. Diczfalusy, L. Ståhle, G. Ahlborg, and J. Wahren Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation J. Lipid Res. 39 1998 1594 1600
5. M. Blanc, W.Y. Hsieh, K.A. Robertson, K.A. Kropp, T. Forster, G. Shui, P. Lacaze, S. Watterson, S.J. Griffiths, and N.J. Spann The transcription factor STAT-1 couples macrophage synthesis of 25-hydroxycholesterol to the interferon antiviral response Immunity 38 2013 106 118
6. M.S. Brown, and J.L. Goldstein A receptor-mediated pathway for cholesterol homeostasis Science 232 1986 34 47
7. M.S. Brown, and J.L. Goldstein A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood Proc. Natl. Acad. Sci. USA 96 1999 11041 11048
8. M.J. Campbell, L.J. Esserman, Y. Zhou, M. Shoemaker, M. Lobo, E. Borman, F. Baehner, A.S. Kumar, K. Adduci, and C. Marx Breast cancer growth prevention by statins Cancer Res. 66 2006 8707 8714
9. N.R. Candelaria, S. Addanki, J. Zheng, T. Nguyen-Vu, H. Karaboga, P. Dey, C. Gabbi, L.L. Vedin, K. Liu, and W. Wu Antiproliferative effects and mechanisms of liver X receptor ligands in pancreatic ductal adenocarcinoma cells PLoS ONE 9 2014 e106289
10. W. Chen, G. Chen, D.L. Head, D.J. Mangelsdorf, and D.W. Russell Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice Cell Metab. 5 2007 73 79
11. G. Choe, S. Horvath, T.F. Cloughesy, K. Crosby, D. Seligson, A. Palotie, L. Inge, B.L. Smith, C.L. Sawyers, and P.S. Mischel Analysis of the phosphatidylinositol 3′-kinase signaling pathway in glioblastoma patients in vivo Cancer Res. 63 2003 2742 2746
12. K. Chu, M. Miyazaki, W.C. Man, and J.M. Ntambi Stearoyl-coenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X receptor activation Mol. Cell. Biol. 26 2006 6786 6798
13. C.P. Chuu, and H.P. Lin Antiproliferative effect of LXR agonists T0901317 and 22(R)-hydroxycholesterol on multiple human cancer cell lines Anticancer Res. 30 2010 3643 3648
14. C.P. Chuu, R.A. Hiipakka, J.M. Kokontis, J. Fukuchi, R.Y. Chen, and S. Liao Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist Cancer Res. 66 2006 6482 6486
15. C.P. Chuu, R.Y. Chen, R.A. Hiipakka, J.M. Kokontis, K.V. Warner, J. Xiang, and S. Liao The liver X receptor agonist T0901317 acts as androgen receptor antagonist in human prostate cancer cells Biochem. Biophys. Res. Commun. 357 2007 341 346
16. J.W. Clendening, and L.Z. Penn Targeting tumor cell metabolism with statins Oncogene 31 2012 4967 4978
17. J.W. Clendening, A. Pandyra, P.C. Boutros, S. El Ghamrasni, F. Khosravi, G.A. Trentin, A. Martirosyan, A. Hakem, R. Hakem, I. Jurisica, and L.Z. Penn Dysregulation of the mevalonate pathway promotes transformation Proc. Natl. Acad. Sci. USA 107 2010 15051 15056
18. C.V. Dang Links between metabolism and cancer Genes Dev. 26 2012 877 890
19. R.A. DeBose-Boyd Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase Cell Res. 18 2008 609 621
20. X. Du, Y.H. Pham, and A.J. Brown Effects of 25-hydroxycholesterol on cholesterol esterification and sterol regulatory element-binding protein processing are dissociable: implications for cholesterol movement to the regulatory pool in the endoplasmic reticulum J. Biol. Chem. 279 2004 47010 47016
21. C. Duval, V. Touche, A. Tailleux, J.C. Fruchart, C. Fievet, V. Clavey, B. Staels, and S. Lestavel Niemann-Pick C1 like 1 gene expression is down-regulated by LXR activators in the intestine Biochem. Biophys. Res. Commun. 340 2006 1259 1263
22. A. El Roz, J.M. Bard, S. Valin, J.M. Huvelin, and H. Nazih Macrophage apolipoprotein E and proliferation of MCF-7 breast cancer cells: role of LXR Anticancer Res. 33 2013 3783 3789
23. R. Evers, G.J. Zaman, L. van Deemter, H. Jansen, J. Calafat, L.C. Oomen, R.P. Oude Elferink, P. Borst, and A.H. Schinkel Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells J. Clin. Invest. 97 1996 1211 1218
24. F.J. Field, S.N. Mathur, and D.R. LaBrecque Cholesterol metabolism in regenerating liver of the rat Am. J. Physiol. 249 1985 G679 G684
25. M.J. Flens, G.J. Zaman, P. van der Valk, M.A. Izquierdo, A.B. Schroeijers, G.L. Scheffer, P. van der Groep, M. de Haas, C.J. Meijer, and R.J. Scheper Tissue distribution of the multidrug resistance protein Am. J. Pathol. 148 1996 1237 1247
26. W. Fu, J. Yao, Y. Huang, Q. Li, W. Li, Z. Chen, F. He, Z. Zhou, and J. Yan LXR agonist regulates the carcinogenesis of PCa via the SOCS3 pathway Cell. Physiol. Biochem. 33 2014 195 204
27. H. Fuda, N.B. Javitt, K. Mitamura, S. Ikegawa, and C.A. Strott Oxysterols are substrates for cholesterol sulfotransferase J. Lipid Res. 48 2007 1343 1352
28. J. Fukuchi, J.M. Kokontis, R.A. Hiipakka, C.P. Chuu, and S. Liao Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells Cancer Res. 64 2004 7686 7689
29. C. Gabbi, H.J. Kim, R. Barros, M. Korach-Andrè, M. Warner, and J.A. Gustafsson Estrogen-dependent gallbladder carcinogenesis in LXRbeta-/- female mice Proc. Natl. Acad. Sci. USA 107 2010 14763 14768
30. C. Ginestier, F. Monville, J. Wicinski, O. Cabaud, N. Cervera, E. Josselin, P. Finetti, A. Guille, G. Larderet, and P. Viens Mevalonate metabolism regulates Basal breast cancer stem cells and is a potential therapeutic target Stem Cells 30 2012 1327 1337
31. J.L. Goldstein, and M.S. Brown Regulation of the mevalonate pathway Nature 343 1990 425 430
32. J.L. Goldstein, and M.S. Brown The LDL receptor Arterioscler. Thromb. Vasc. Biol. 29 2009 431 438
33. J.L. Goldstein, R.A. DeBose-Boyd, and M.S. Brown Protein sensors for membrane sterols Cell 124 2006 35 46
34. H. Gong, P. Guo, Y. Zhai, J. Zhou, H. Uppal, M.J. Jarzynka, W.C. Song, S.Y. Cheng, and W. Xie Estrogen deprivation and inhibition of breast cancer growth in vivo through activation of the orphan nuclear receptor liver X receptor Mol. Endocrinol. 21 2007 1781 1790
35. D. Guo, F. Reinitz, M. Youssef, C. Hong, D. Nathanson, D. Akhavan, D. Kuga, A.N. Amzajerdi, H. Soto, and S. Zhu An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway Cancer Discov 1 2011 442 456
36. B.A. Janowski, P.J. Willy, T.R. Devi, J.R. Falck, and D.J. Mangelsdorf An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha Nature 383 1996 728 731
37. B.A. Janowski, M.J. Grogan, S.A. Jones, G.B. Wisely, S.A. Kliewer, E.J. Corey, and D.J. Mangelsdorf Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta Proc. Natl. Acad. Sci. USA 96 1999 266 271
38. B.A. Janowski, B. Shan, and D.W. Russell The hypocholesterolemic agent LY295427 reverses suppression of sterol regulatory element-binding protein processing mediated by oxysterols J. Biol. Chem. 276 2001 45408 45416
39. S.B. Joseph, B.A. Laffitte, P.H. Patel, M.A. Watson, K.E. Matsukuma, R. Walczak, J.L. Collins, T.F. Osborne, and P. Tontonoz Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors J. Biol. Chem. 277 2002 11019 11025
40. A.A. Kandutsch, H.W. Chen, and H.J. Heiniger Biological activity of some oxygenated sterols Science 201 1978 498 501
41. M.A. Kennedy, G.C. Barrera, K. Nakamura, A. Baldán, P. Tarr, M.C. Fishbein, J. Frank, O.L. Francone, and P.A. Edwards ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation Cell Metab. 1 2005 121 131
42. T. Kunická, and P. Souček Importance of ABCC1 for cancer therapy and prognosis Drug Metab. Rev. 46 2014 325 342
43. B.A. Laffitte, S.B. Joseph, M. Chen, A. Castrillo, J. Repa, D. Wilpitz, D. Mangelsdorf, and P. Tontonoz The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions Mol. Cell. Biol. 23 2003 2182 2191
44. E.M. Leslie, R.G. Deeley, and S.P. Cole Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense Toxicol. Appl. Pharmacol. 204 2005 216 237
45. Y.C. Li, M.J. Park, S.K. Ye, C.W. Kim, and Y.N. Kim Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents Am. J. Pathol. 168 2006 1107 1118 quiz 1404-1405
46. Y. Liu Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer Prostate Cancer Prostatic Dis. 9 2006 230 234
47. G. Llaverias, C. Danilo, I. Mercier, K. Daumer, F. Capozza, T.M. Williams, F. Sotgia, M.P. Lisanti, and P.G. Frank Role of cholesterol in the development and progression of breast cancer Am. J. Pathol. 178 2011 402 412
48. G. Lo Sasso, N. Celli, M. Caboni, S. Murzilli, L. Salvatore, A. Morgano, M. Vacca, T. Pagliani, P. Parini, and A. Moschetta Down-regulation of the LXR transcriptome provides the requisite cholesterol levels to proliferating hepatocytes Hepatology 51 2010 1334 1344
49. G. Lo Sasso, S. Murzilli, L. Salvatore, I. D'Errico, M. Petruzzelli, P. Conca, Z.Y. Jiang, L. Calabresi, P. Parini, and A. Moschetta Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis Cell Metab. 12 2010 187 193
50. G. Lo Sasso, F. Bovenga, S. Murzilli, L. Salvatore, G. Di Tullio, N. Martelli, A. D'Orazio, S. Rainaldi, M. Vacca, and A. Mangia Liver X receptors inhibit proliferation of human colorectal cancer cells and growth of intestinal tumors in mice Gastroenterology 144 2013 1497 1507 e1-e13
51. J. MacMicking, Q.W. Xie, and C. Nathan Nitric oxide and macrophage function Annu. Rev. Immunol. 15 1997 323 350
52. C.A. Meloche, and C.N. Falany Expression and characterization of the human 3 beta-hydroxysteroid sulfotransferases (SULT2B1a and SULT2B1b) J. Steroid Biochem. Mol. Biol. 77 2001 261 269
53. A. Moschetta Nuclear receptor LXR as a novel therapeutic antitumoral target in glioblastoma Cancer Discov 1 2011 381 382
54. E.R. Nelson, S.E. Wardell, J.S. Jasper, S. Park, S. Suchindran, M.K. Howe, N.J. Carver, R.V. Pillai, P.M. Sullivan, and V. Sondhi 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology Science 342 2013 1094 1098
55. T. Nguyen-Vu, L.L. Vedin, K. Liu, P. Jonsson, J.Z. Lin, N.R. Candelaria, L.P. Candelaria, S. Addanki, C. Williams, and J.A. Gustafsson Liver × receptor ligands disrupt breast cancer cell proliferation through an E2F-mediated mechanism Breast Cancer Res. 15 2013 R51
56. D.J. Peet, S.D. Turley, W. Ma, B.A. Janowski, J.M. Lobaccaro, R.E. Hammer, and D.J. Mangelsdorf Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha Cell 93 1998 693 704
57. N. Pencheva, H. Tran, C. Buss, D. Huh, M. Drobnjak, K. Busam, and S.F. Tavazoie Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis Cell 151 2012 1068 1082
58. N. Pencheva, C.G. Buss, J. Posada, T. Merghoub, and S.F. Tavazoie Broad-spectrum therapeutic suppression of metastatic melanoma through nuclear hormone receptor activation Cell 156 2014 986 1001
59. M.C. Phillips Molecular mechanisms of cellular cholesterol efflux J. Biol. Chem. 289 2014 24020 24029
60. A.J. Pommier, G. Alves, E. Viennois, S. Bernard, Y. Communal, B. Sion, G. Marceau, C. Damon, K. Mouzat, and F. Caira Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells Oncogene 29 2010 2712 2723
61. A. Radhakrishnan, Y. Ikeda, H.J. Kwon, M.S. Brown, and J.L. Goldstein Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig Proc. Natl. Acad. Sci. USA 104 2007 6511 6518
62. S. Rao, M. Lowe, T.W. Herliczek, and K. Keyomarsi Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53 Oncogene 17 1998 2393 2402
63. J.J. Repa, G. Liang, J. Ou, Y. Bashmakov, J.M. Lobaccaro, I. Shimomura, B. Shan, M.S. Brown, J.L. Goldstein, and D.J. Mangelsdorf Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta Genes Dev. 14 2000 2819 2830
64. J.J. Repa, S.D. Turley, J.A. Lobaccaro, J. Medina, L. Li, K. Lustig, B. Shan, R.A. Heyman, J.M. Dietschy, and D.J. Mangelsdorf Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers Science 289 2000 1524 1529
65. J.J. Repa, K.E. Berge, C. Pomajzl, J.A. Richardson, H. Hobbs, and D.J. Mangelsdorf Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta J. Biol. Chem. 277 2002 18793 18800
66. J.J. Rough, M.A. Monroy, S. Yerrum, and J.M. Daly Anti-proliferative effect of LXR agonist T0901317 in ovarian carcinoma cells J Ovarian Res 3 2010 13
67. D.W. Russell Oxysterol biosynthetic enzymes Biochim. Biophys. Acta 1529 2000 126 135
68. R. Sato Sterol metabolism and SREBP activation Arch. Biochem. Biophys. 501 2010 177 181
69. E.J. Scheinman, R. Rostoker, and D. Leroith Cholesterol affects gene expression of the Jun family in colon carcinoma cells using different signaling pathways Mol. Cell. Endocrinol. 374 2013 101 107
70. K. Simons, and E. Ikonen How cells handle cholesterol Science 290 2000 1721 1726
71. K.R. Solomon, and M.R. Freeman The complex interplay between cholesterol and prostate malignancy Urol. Clin. North Am. 38 2011 243 259
72. J.H. Song, M.C. Tse, A. Bellail, S. Phuphanich, F. Khuri, N.M. Kneteman, and C. Hao Lipid rafts and nonrafts mediate tumor necrosis factor related apoptosis-inducing ligand induced apoptotic and nonapoptotic signals in non small cell lung carcinoma cells Cancer Res. 67 2007 6946 6955
73. G. Sorrentino, N. Ruggeri, V. Specchia, M. Cordenonsi, M. Mano, S. Dupont, A. Manfrin, E. Ingallina, R. Sommaggio, and S. Piazza Metabolic control of YAP and TAZ by the mevalonate pathway Nat. Cell Biol. 16 2014 357 366
74. S.E. Trasino, Y.S. Kim, and T.T. Wang Ligand, receptor, and cell type-dependent regulation of ABCA1 and ABCG1 mRNA in prostate cancer epithelial cells Mol. Cancer Ther. 8 2009 1934 1945
75. S. Uno, K. Endo, Y. Jeong, K. Kawana, H. Miyachi, Y. Hashimoto, and M. Makishima Suppression of beta-catenin signaling by liver X receptor ligands Biochem. Pharmacol. 77 2009 186 195
76. T. Van de Sande, T. Roskams, E. Lerut, S. Joniau, H. Van Poppel, G. Verhoeven, and J.V. Swinnen High-level expression of fatty acid synthase in human prostate cancer tissues is linked to activation and nuclear localization of Akt/PKB J. Pathol. 206 2005 214 219
77. C. Vedhachalam, P.T. Duong, M. Nickel, D. Nguyen, P. Dhanasekaran, H. Saito, G.H. Rothblat, S. Lund-Katz, and M.C. Phillips Mechanism of ATP-binding cassette transporter A1-mediated cellular lipid efflux to apolipoprotein A-I and formation of high density lipoprotein particles J. Biol. Chem. 282 2007 25123 25130
78. L.L. Vedin, S.A. Lewandowski, P. Parini, J.A. Gustafsson, and K.R. Steffensen The oxysterol receptor LXR inhibits proliferation of human breast cancer cells Carcinogenesis 30 2009 575 579
79. L.L. Vedin, J.A. Gustafsson, and K.R. Steffensen The oxysterol receptors LXRα and LXRβ suppress proliferation in the colon Mol. Carcinog. 52 2013 835 844
80. A. Venkateswaran, B.A. Laffitte, S.B. Joseph, P.A. Mak, D.C. Wilpitz, P.A. Edwards, and P. Tontonoz Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha Proc. Natl. Acad. Sci. USA 97 2000 12097 12102
81. Q. Wang, X. Ma, Y. Chen, L. Zhang, M. Jiang, X. Li, R. Xiang, R. Miao, D.P. Hajjar, Y. Duan, and J. Han Identification of interferon-γ as a new molecular target of liver X receptor Biochem. J. 459 2014 345 354
82. J. Wang, M.A. Mitsche, D. Luetjohann, J.C. Cohen, X.S. Xie, and H.H. Hobbs Relative Roles of ABCG5/ABCG8 in Liver and Intestine J. Lipid Res. 56 2015 319 330
83. J. Wejde, M. Hjertman, M. Carlberg, B. Egestad, W.J. Griffiths, J. Sjövall, and O. Larsson Dolichol-like lipids with stimulatory effect on DNA synthesis: substrates for protein dolichylation? J. Cell. Biochem. 71 1998 502 514
84. W. Wente, M.B. Brenner, H. Zitzer, J. Gromada, and A.M. Efanov Activation of liver X receptors and retinoid X receptors induces growth arrest and apoptosis in insulin-secreting cells Endocrinology 148 2007 1843 1849
85. P.J. Willy, K. Umesono, E.S. Ong, R.M. Evans, R.A. Heyman, and D.J. Mangelsdorf LXR, a nuclear receptor that defines a distinct retinoid response pathway Genes Dev. 9 1995 1033 1045
86. Y.F. Yang, Y.H. Jan, Y.P. Liu, C.J. Yang, C.Y. Su, Y.C. Chang, T.C. Lai, J. Chiou, H.Y. Tsai, and J. Lu Squalene synthase induces tumor necrosis factor receptor 1 enrichment in lipid rafts to promote lung cancer metastasis Am. J. Respir. Crit. Care Med. 190 2014 675 687
87. Y. Yoshii, T. Furukawa, N. Oyama, Y. Hasegawa, Y. Kiyono, R. Nishii, A. Waki, A.B. Tsuji, C. Sogawa, and H. Wakizaka Fatty acid synthase is a key target in multiple essential tumor functions of prostate cancer: uptake of radiolabeled acetate as a predictor of the targeted therapy outcome PLoS ONE 8 2013 e64570
88. X.H. Yu, K. Qian, N. Jiang, X.L. Zheng, F.S. Cayabyab, and C.K. Tang ABCG5/ABCG8 in cholesterol excretion and atherosclerosis Clin. Chim. Acta 428 2014 82 88
89. M.R. Zaidi, and G. Merlino The two faces of interferon-γ in cancer Clin. Cancer Res. 17 2011 6118 6124
90. N. Zelcer, C. Hong, R. Boyadjian, and P. Tontonoz LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor Science 325 2009 100 104
91. Y. Zhang, J.J. Repa, K. Gauthier, and D.J. Mangelsdorf Regulation of lipoprotein lipase by the oxysterol receptors, LXRalpha and LXRbeta J. Biol. Chem. 276 2001 43018 43024
92. W. Zhang, H. Jiang, J. Zhang, Y. Zhang, A. Liu, Y. Zhao, X. Zhu, Z. Lin, and X. Yuan Liver X receptor activation induces apoptosis of melanoma cell through caspase pathway Cancer Cell Int. 14 2014 16